These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 33907889)

  • 1. Assessment of muscular strength and functional capacity in the juvenile and adult myotonic dystrophy type 1 population: a 3-year follow-up study.
    Roussel MP; Fiset MM; Gauthier L; Lavoie C; McNicoll É; Pouliot L; Gagnon C; Duchesne E
    J Neurol; 2021 Nov; 268(11):4221-4237. PubMed ID: 33907889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 9-year follow-up study of quantitative muscle strength changes in myotonic dystrophy type 1.
    Gagnon C; Petitclerc É; Kierkegaard M; Mathieu J; Duchesne É; Hébert LJ
    J Neurol; 2018 Jul; 265(7):1698-1705. PubMed ID: 29785524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strength-training effectively alleviates skeletal muscle impairments in myotonic dystrophy type 1.
    Roussel MP; Hébert LJ; Duchesne E
    Neuromuscul Disord; 2020 Apr; 30(4):283-293. PubMed ID: 32340814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationships between Lower Limb Muscle Strength Impairments and Physical Limitations in DM1.
    Petitclerc É; Hébert LJ; Mathieu J; Desrosiers J; Gagnon C
    J Neuromuscul Dis; 2018; 5(2):215-224. PubMed ID: 29865087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strength training and aerobic exercise training for muscle disease.
    Voet NB; van der Kooi EL; van Engelen BG; Geurts AC
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD003907. PubMed ID: 31808555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validity of the Mini-BESTest in adults with myotonic dystrophy type 1.
    Duchesne E; Hébert LJ; Mathieu J; Côté I; Roussel MP; Gagnon C
    Muscle Nerve; 2020 Jul; 62(1):95-102. PubMed ID: 32314404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Explanatory factors of dynamic balance impairment in myotonic dystrophy type 1.
    Bélair N; Côté I; Gagnon C; Mathieu J; Duchesne E
    Muscle Nerve; 2022 Jun; 65(6):683-687. PubMed ID: 35212003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic exercise mitigates disease mechanisms and improves muscle function in myotonic dystrophy type 1 mice.
    Manta A; Stouth DW; Xhuti D; Chi L; Rebalka IA; Kalmar JM; Hawke TJ; Ljubicic V
    J Physiol; 2019 Mar; 597(5):1361-1381. PubMed ID: 30628727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What Happened with Muscle Force, Dynamic Stability And Falls? A 10-Year Longitudinal Follow-Up in Adults with Myotonic Dystrophy Type 1.
    Hammarén E; Kollén L
    J Neuromuscul Dis; 2021; 8(6):1007-1016. PubMed ID: 34151851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural history of skeletal muscle involvement in myotonic dystrophy type 1: a retrospective study in 204 cases.
    Bouchard JP; Cossette L; Bassez G; Puymirat J
    J Neurol; 2015 Feb; 262(2):285-93. PubMed ID: 25380585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Major involvement of trunk muscles in myotonic dystrophy type 1.
    Solbakken G; Ørstavik K; Hagen T; Dietrichs E; Naerland T
    Acta Neurol Scand; 2016 Dec; 134(6):467-473. PubMed ID: 26984572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What is known about the effects of exercise or training to reduce skeletal muscle impairments of patients with myotonic dystrophy type 1? A scoping review.
    Roussel MP; Morin M; Gagnon C; Duchesne E
    BMC Musculoskelet Disord; 2019 Mar; 20(1):101. PubMed ID: 30836978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in Physiopathological Markers in Myotonic Dystrophy Type 1 Skeletal Muscle: A 3-Year Follow-up Study.
    Roussel MP; Ravel-Chapuis A; Gobin J; Jasmin BJ; Leduc-Gaudet JP; Gagnon C; Duchesne E
    J Neuromuscul Dis; 2024 Jul; ():. PubMed ID: 39031377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lower limb muscle strength impairment in late-onset and adult myotonic dystrophy type 1 phenotypes.
    Petitclerc É; Hébert LJ; Mathieu J; Desrosiers J; Gagnon C
    Muscle Nerve; 2017 Jul; 56(1):57-63. PubMed ID: 27784130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intra-Rater Reliability and Concurrent Validity of Quantified Muscle Testing for Maximal Knee Extensors Strength in Men with Myotonic Dystrophy Type 1.
    Roussel MP; Hébert LJ; Duchesne E
    J Neuromuscul Dis; 2019; 6(2):233-240. PubMed ID: 31127731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects and Acceptability of an Individualized Home-Based 10-Week Training Program in Adults with Myotonic Dystrophy Type 1.
    Lessard I; Gaboury S; Gagnon C; Bouchard K; Chapron K; Lavoie M; Lapointe P; Duchesne E
    J Neuromuscul Dis; 2021; 8(1):137-149. PubMed ID: 33252090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ankle Strength Impairments in Myotonic Dystrophy Type 1: A Five-Year Follow-up.
    Hébert LJ; Vial C; Hogrel JY; Puymirat J
    J Neuromuscul Dis; 2018; 5(3):321-330. PubMed ID: 29889079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive behaviour therapy plus aerobic exercise training to increase activity in patients with myotonic dystrophy type 1 (DM1) compared to usual care (OPTIMISTIC): study protocol for randomised controlled trial.
    van Engelen B;
    Trials; 2015 May; 16():224. PubMed ID: 26002596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Responsiveness of outcome measures in myotonic dystrophy type 1.
    Knak KL; Sheikh AM; Witting N; Vissing J
    Ann Clin Transl Neurol; 2020 Aug; 7(8):1382-1391. PubMed ID: 32672404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is one trial enough for repeated testing? Same-day assessments of walking, mobility and fine hand use in people with myotonic dystrophy type 1.
    Kierkegaard M; Petitclerc E; Hébert LJ; Gagnon C
    Neuromuscul Disord; 2017 Feb; 27(2):153-158. PubMed ID: 28062219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.